Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-08

Clinical Trial Update: Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the addition of sodium nitroprusside to treatment as usual in schizophrenia has completed, assessing the safety and efficacy of the a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium nitroprusside (sodium nitroprusside)

Snippet

Sponsor: University of Sao Paulo | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED